I joined the Princess Máxima Center as a basic researcher and pediatrician in training in June 2018. My primary research interest lies in understanding the molecular biology of pediatric soft tissue sarcomas (STS) and to use that knowledge to develop new treatment options for patients suffering from these tumors. To this end, I study establishment procedures for novel preclinical models of pediatrist STS (i.e., tumor organoid models) as well as bulk and single-cell genomics of these tumors. I am furthermore member of the molecular tumor board of the Dutch iTHER as well as the German INFORM pediatric precision medicine trial.
My hobbies include sports (running, bootcamp) and gaming (board games, tabletop role-playing games, video games). I am the proud father of a boy and a girl.
The team
Meet our group leader: Jarno Drost
Jarno Drost received his PhD in the group of Reuven Agami (Netherlands Cancer Institute) studying malignant transformation using RNA interference screens. He subsequently joined the lab of Hans Clevers (Hubrecht Institute) where he used organoid technology in combination with CRISPR/Cas9 gene editing to study multistep tumorigenesis. Since 2016, he is group leader at the Princess Máxima Center for Pediatric Oncology. In 2019, he became an Oncode Investigator. He received several awards, including the Bas Mulder Young Investigator Award from the Dutch Cancer Society, the ERC Starting and NWO-Vidi grants, and the AACR St. Baldrick’s career development award for emerging leaders in the field of pediatric oncology.
